PRASAD R KUDALKAR
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology FAIRFIELD, OH NPI 1013094382
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology OH ABBVIE INC. All categories
General Payments — all program years on this page
$2,899.26
- Category: General Payments
- Program years: PY2018–2024
- Record count: 115
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $706.27 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $706.27 | 36 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $197.79 | 12 |
| Merck Sharp & Dohme Corporation | $69.71 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $69.00 | 3 |
| JAZZ PHARMACEUTICALS INC. | $46.27 | 2 |
| Acerta Pharma LLC | $40.33 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.58 | 1 |
| Genmab U.S., Inc. | $23.92 | 1 |
| Stemline Therapeutics Inc. | $22.74 | 1 |
| GENZYME CORPORATION | $20.29 | 1 |
| SOBI, INC | $19.78 | 1 |
| Gilead Sciences, Inc. | $19.74 | 1 |
| Daiichi Sankyo Inc. | $18.96 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.69 | 1 |
| Lilly USA, LLC | $18.51 | 1 |
| GlaxoSmithKline, LLC. | $18.40 | 1 |
| EISAI INC. | $17.49 | 1 |
| Janssen Biotech, Inc. | $17.33 | 1 |
| Celgene Corporation | $17.19 | 1 |
| Legend Biotech USA Inc. | $16.55 | 1 |
By program year
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.